Skip to content
October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
From Bench to Bedside: How the Broad Institute is Redefining the Frontiers of Modern Medicine from-bench-to-bedside-how-the-broad-institute-is-redefining-the-frontiers-of-modern-medicine
  • Genomics and Precision Medicine

From Bench to Bedside: How the Broad Institute is Redefining the Frontiers of Modern Medicine

Ammar Sabilarrohman July 17, 2026
In the quiet laboratories of Cambridge, Massachusetts, a scientific revolution is unfolding. The Broad Institute of MIT...
Read More Read more about From Bench to Bedside: How the Broad Institute is Redefining the Frontiers of Modern Medicine
Navigating Hair Loss During Cancer Treatment: A Comprehensive Guide to Empowerment and Choices navigating-hair-loss-during-cancer-treatment-a-comprehensive-guide-to-empowerment-and-choices
  • Survivorship and Post-Treatment

Navigating Hair Loss During Cancer Treatment: A Comprehensive Guide to Empowerment and Choices

Pevita Pearce July 17, 2026
For many individuals, a cancer diagnosis brings a whirlwind of medical decisions, emotional adjustments, and physical transformations....
Read More Read more about Navigating Hair Loss During Cancer Treatment: A Comprehensive Guide to Empowerment and Choices
A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients a-new-era-in-medicine-crispr-based-gene-therapy-casgevy-approved-for-nhs-patients
  • Genomics and Precision Medicine

A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

Azzam Bilal Chamdy July 17, 2026
The landscape of modern medicine has undergone a seismic shift. For thousands of patients in England suffering...
Read More Read more about A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients
Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data roche-expands-trontinemabs-horizon-in-alzheimers-fight-with-pre-symptomatic-trial-and-promising-phase-iii-data
  • Medical Research and Clinical Trials

Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data

Nana Wu July 17, 2026
London, UK – July 25, 2026 – In a significant stride towards a more comprehensive approach to...
Read More Read more about Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data
Biotech Breakthrough: Veradermics’ Oral Minoxidil Trial Marks Potential Paradigm Shift in Hair Loss Treatment biotech-breakthrough-veradermics-oral-minoxidil-trial-marks-potential-paradigm-shift-in-hair-loss-treatment
  • Treatment Innovations

Biotech Breakthrough: Veradermics’ Oral Minoxidil Trial Marks Potential Paradigm Shift in Hair Loss Treatment

Asep Darmawan July 17, 2026
In the historically stagnant market of hair loss therapeutics, a new contender is rewriting the narrative. Veradermics,...
Read More Read more about Biotech Breakthrough: Veradermics’ Oral Minoxidil Trial Marks Potential Paradigm Shift in Hair Loss Treatment
FDA Expands Scope of Palbociclib: A New Maintenance Strategy for HR+/HER2+ Metastatic Breast Cancer fda-expands-scope-of-palbociclib-a-new-maintenance-strategy-for-hr-her2-metastatic-breast-cancer
  • Clinical Oncology Education

FDA Expands Scope of Palbociclib: A New Maintenance Strategy for HR+/HER2+ Metastatic Breast Cancer

Iffa Jayyana July 17, 2026
In a significant development for oncology therapeutics, the U.S. Food and Drug Administration (FDA) has granted approval...
Read More Read more about FDA Expands Scope of Palbociclib: A New Maintenance Strategy for HR+/HER2+ Metastatic Breast Cancer
The God Molecule Gamble: Inside Eli Lilly’s $3.8 Billion Pivot to Psychedelic Medicine the-god-molecule-gamble-inside-eli-lillys-3-8-billion-pivot-to-psychedelic-medicine
  • Chemotherapy and Targeted Therapy

The God Molecule Gamble: Inside Eli Lilly’s $3.8 Billion Pivot to Psychedelic Medicine

Dwi Wanna July 17, 2026
In a move that signals a seismic shift for the pharmaceutical industry, Eli Lilly has announced a...
Read More Read more about The God Molecule Gamble: Inside Eli Lilly’s $3.8 Billion Pivot to Psychedelic Medicine
A Legacy of Compassion: How Sharsheret Transformed Cancer Support for Jewish Families a-legacy-of-compassion-how-sharsheret-transformed-cancer-support-for-jewish-families-1
  • Survivorship and Post-Treatment

A Legacy of Compassion: How Sharsheret Transformed Cancer Support for Jewish Families

Jia Lissa July 17, 2026
By Editorial Staff December 01, 2025 In the landscape of modern patient advocacy, few organizations have managed...
Read More Read more about A Legacy of Compassion: How Sharsheret Transformed Cancer Support for Jewish Families
From Survival to Solidarity: The Remarkable Journey of Sergio Flores from-survival-to-solidarity-the-remarkable-journey-of-sergio-flores
  • Integrative Oncology and Holistic Care

From Survival to Solidarity: The Remarkable Journey of Sergio Flores

Lina Irawan July 17, 2026
For many, Pride Month is a vibrant display of celebration, a time of parades and parties that...
Read More Read more about From Survival to Solidarity: The Remarkable Journey of Sergio Flores
The Psychedelic Frontier: Eli Lilly’s $3.8 Billion Bet on AtaiBeckley Signals a New Era for Big Pharma the-psychedelic-frontier-eli-lillys-3-8-billion-bet-on-ataibeckley-signals-a-new-era-for-big-pharma
  • Chemotherapy and Targeted Therapy

The Psychedelic Frontier: Eli Lilly’s $3.8 Billion Bet on AtaiBeckley Signals a New Era for Big Pharma

Evan Lee Salim July 16, 2026
In a move that marks a tectonic shift in the pharmaceutical landscape, Eli Lilly has announced its...
Read More Read more about The Psychedelic Frontier: Eli Lilly’s $3.8 Billion Bet on AtaiBeckley Signals a New Era for Big Pharma

Posts pagination

Previous 1 … 518 519 520 521 522 523 524 … 835 Next

Recent Posts

  • Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors
  • Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial
  • Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment
  • Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress
  • Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-the-silent-threat-groundbreaking-st-jude-research-reveals-genetic-blueprint-of-secondary-cancers-in-childhood-survivors
  • Medical Research and Clinical Trials

Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors

Layla Zulfa October 29, 2026
eli-lillys-retatrutide-surges-ahead-in-weight-loss-race-outperforming-novo-nordisks-ozempic-in-landmark-trial
  • Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial

Ammar Sabilarrohman October 29, 2026
reclaiming-intimacy-navigating-sexual-health-after-breast-cancer-treatment
  • Patient Advocacy and Support

Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment

Basiran October 29, 2026
Scientists working with samples in laboratory
  • Patient Advocacy and Support

Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress

Azzam Bilal Chamdy October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.